|
Review: The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection Poli G, et al.
Journal of Leukocyte Biology
2003;74:750-756
Link Both urokinase-type plasminogen activator (uPA) and its glycosyl-phosphatidyl-inositol (GPI) anchored receptor (uPAR), as well as their soluble forms detectable in plasma and other body fluids, represent markers of cancer development and metastasis, and they have been recently described as predictors of human immunodeficiency virus (HIV) disease progression, independent of CD4+ T cell counts and viremia.
—Posted: December 2, 2003
More journal headlines: This month | Last month | Search archive
|
